INFLIXIMAB THERAPY IN MANAGING PEDIATRIC IBD
- Autori: Accomando, S.; Albino, C.; Di Fiore, A.; Ferraro, F.; Maniscalchi, V.; Corsello, G.
- Anno di pubblicazione: 2012
- Tipologia: Abstract in atti di convegno pubblicato in rivista
- OA Link: http://hdl.handle.net/10447/79044
Abstract
Treatment of IBD is complex and based on different drugs. The biological treatments act on different stages of immunophysiopathological processes of the disease to change the evolution or natural history. At present the most studied and used biological drug is a chimerical monoclonal antibody to TNF alpha known as infliximab